Isoxazol-4-ylboronic Acid | CAS 1008139-25-0 | ≥98%

Tandem Suzuki coupling / isoxazole fragmentation / cyanomethylation: Isoxazol-4-ylboronic acid and its pinacol ester serve as unique cyanomethylation reagents through a palladium-catalysed domino reaction sequence. In this one-pot process, the boronic acid first undergoes standard Suzuki–Miyaura coupling with an aryl or heteroaryl halide, after which the isoxazole ring undergoes base-promoted fragmentation followed by deformylation, ultimately delivering arylacetonitriles (ArCH₂CN) — a synthetically valuable functional group — in a single operation with yields up to 88%. Velcicky et al. (J. Am. Chem. Soc. 2011, 133, 6948). Optimised conditions use PdCl₂(dppf) as catalyst with KF as base in DMSO/H₂O at 130 °C. The isoxazole ring acts as a masked cyanomethyl group — it survives the cross-coupling step intact and fragments only upon exposure to base, providing chemoselectivity that cannot be achieved with free cyanomethyl anions or conventional cyanation reagents. The resulting arylacetonitriles are valuable intermediates that can be further hydrolysed to arylacetic acids, reduced to phenethylamines, or elaborated into heterocyclic scaffolds. A two-step variant of this protocol (Lindsay-Scott et al., Org. Lett. 2015, 17, 476) separates the Suzuki coupling from the fragmentation, offering additional flexibility for sensitive substrates where the high-temperature one-pot conditions are incompatible with other functional groups.

DNA-encoded library (DEL) synthesis: Isoxazol-4-ylboronic acid has been specifically developed as a DNA-compatible cyanomethylation reagent for the synthesis of DNA-encoded chemical libraries (Zhang et al., Org. Lett. 2023, 25, 6931). DELs are one of the most important modern platforms for high-throughput drug discovery, enabling the screening of millions of compounds against therapeutic targets in a single experiment. The tandem Suzuki coupling / isoxazole fragmentation process does not cause significant DNA damage, making it suitable for on-DNA chemistry. The resulting DNA-tagged arylacetonitriles can be subsequently converted to the corresponding arylacetic acids, expanding the diversity of carboxylic acid building blocks accessible within DEL synthesis workflows.

Suzuki–Miyaura cross-coupling: Independent of the fragmentation pathway, isoxazol-4-ylboronic acid functions as a conventional heteroaryl boronic acid in Suzuki–Miyaura cross-coupling reactions when milder conditions are employed — specifically, lower temperatures and weaker bases that do not trigger isoxazole ring fragmentation. Under these conditions, the intact 4-isoxazolyl group is transferred to the aryl halide coupling partner, producing 4-aryl- or 4-heteroarylisoxazole products. The isoxazole ring is weakly aromatic and electron-poor relative to furan or pyrrole, which means the boronic acid at C-4 is moderately susceptible to protodeboronation under prolonged basic aqueous conditions. For optimal results in standard Suzuki coupling, shorter reaction times, milder bases such as K₂CO₃, and lower temperatures are recommended.

Medicinal chemistry and bioisosteric replacement: The isoxazole ring is a well-validated medicinal chemistry scaffold that appears in numerous approved drugs and clinical candidates across anti-inflammatory, antimicrobial, analgesic, and anticonvulsant therapeutic areas. Isoxazol-4-ylboronic acid enables direct Suzuki-mediated installation of the isoxazole pharmacophore onto drug scaffolds at the C-4 position. Isoxazole is established as a bioisostere for furan, amide, and ester functional groups — replacing a metabolically labile furan ring with an isoxazole in a drug candidate typically improves metabolic stability and reduces toxicity risk associated with furan epoxidation, while maintaining similar spatial geometry and hydrogen-bond acceptor capacity. Boronic acids themselves are pharmacologically active motifs — they form reversible covalent bonds with serine residues in enzyme active sites. Heteroaryl boronic acids including isoxazolylboronic acid have been explored as fragment screening hits against serine hydrolases, proteases, and autotaxin.

Heterocyclic building block chemistry and fragmentation precursors: Beyond cyanomethylation, the controlled fragmentation of the isoxazole ring provides access to a range of 1,3-bifunctional intermediates — specifically β-aminoenones and related acyclic precursors — that are useful for the de novo construction of other heterocyclic ring systems including pyrimidines, pyrazoles, and pyrroles via ring-opening / ring-closing cascade (ROCC) sequences. Isoxazol-4-ylboronic acid thus serves not only as a coupling partner but as a latent precursor to structurally diverse heterocyclic products.